C
Cadrenal Therapeutics Inc
NASDAQ:CVKD
Cadrenal Therapeutics Inc
NASDAQ:CVKD
Price:
7.995
USD
-3.67%
Market Closed
Market Cap:
$18.7m
Balance Sheet
Balance Sheet Decomposition
Cadrenal Therapeutics Inc
Cadrenal Therapeutics Inc
Balance Sheet Decomposition is not available for
Cadrenal Therapeutics Inc
Cadrenal Therapeutics Inc
Balance Sheet
Cadrenal Therapeutics Inc
Cadrenal Therapeutics Inc
Currency: USD
| Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|
| Assets | ||||
| Cash & Cash Equivalents |
0
|
8
|
10
|
|
| Cash |
0
|
8
|
10
|
|
| Total Receivables |
0
|
0
|
0
|
|
| Other Current Assets |
1
|
0
|
0
|
|
| Total Current Assets |
1
|
8
|
10
|
|
| PP&E Net |
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
|
| Total Assets |
1
N/A
|
9
+992%
|
10
+19%
|
|
| Liabilities | ||||
| Accounts Payable |
0
|
0
|
2
|
|
| Accrued Liabilities |
1
|
1
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
|
| Total Current Liabilities |
1
|
1
|
3
|
|
| Long-Term Debt |
1
|
0
|
0
|
|
| Other Liabilities |
4
|
0
|
0
|
|
| Total Liabilities |
6
N/A
|
1
-87%
|
3
+225%
|
|
| Equity | ||||
| Common Stock |
0
|
0
|
0
|
|
| Retained Earnings |
7
|
15
|
26
|
|
| Additional Paid In Capital |
1
|
23
|
33
|
|
| Total Equity |
6
N/A
|
8
N/A
|
7
-3%
|
|
| Total Liabilities & Equity |
1
N/A
|
9
+992%
|
10
+19%
|
|
| Shares Outstanding | ||||
| Common Shares Outstanding |
8
|
1
|
2
|
|
Switch to:
Switch to:
See Also
Discover More
